Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $61.56 USD
Change Today -0.24 / -0.39%
Volume 218.4K
ALKS On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 10:15 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert A. Breyer

Director, Member of Nominating & Corporate Governance Committee and Member of Audit & Risk Committee, Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 2 different industries.

See Board Relationships
70$565,893

Background*

Mr. Robert A. Breyer, also known as Bob served as the President of Alkermes Inc. from July 1994 to December 2001 and its Chief Operating Officer from July 1994 to February 2001. Mr. Breyer was a Part-Time Employee of Alkermes. From August 1991 to December 1993, he served as the President and General Manager of Eli Lilly Italy, a subsidiary of Eli Lilly and Company. From September 1987 to August 1991, he served as Senior Vice President of Marketing and Sales at IVAC Corporation, ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 772 8000
Fax: --

Board Members Memberships*

1994-Present
Director, Member of Nominating & Corporate Governance Committee and Member of Audit & Risk Committee
2005-N/A
Former Director

Education*

BS 1966
North Dakota State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$96,500
Total Calculated Compensation$565,893
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALKS:US $61.52 USD -0.28

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
$1.0M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$830.0K
Vinita Gupta Chief Executive Officer and Executive Director
Lupin Limited
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee
Emergent BioSolutions, Inc.
$1.2M
Alessandro E. Della Chà LL.MChief Executive Officer and Director
Cosmo Pharmaceuticals S.p.A.
€1.9M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.